[1] WHO global TB program, UNAIDS. Preventive therapy against TB in people living with HIV[J]. Weekly Epidemioloical Record,1999,74(46):385-398.
[2] J. P. Narain, et al. HTV-associated TB in developing counties: epidemiology and strategies for prevention [J].Tubercle and Lung Disease,1992,73(6):311-321.
[3] Selwgn PA, Hartel D, Lewis VA, et al. A prospective study of the risk of tuberculosis among intravenous drug users with HIV infection [J]. N Engl J Med,1989,320:545-550.
[4] Small PM, Shafer RW, Hopewell PC, et al. Exogenous re-infection with multi-dmg-resistant mycobacterium TB in patients with advanced HIV infection [J]. N Engl J Med, 1993,328:1137-1144.
[5] Edlin BR, Tokars JI, Grieco MH,et al. An outbreak of multi-drug-resistant TB among hospitalized patients with the acquired immuno-deficiency syndrome[J]. N Engl J Med, 1992,326:1514-1421.
[6] Kevin M De Cock. Preventive therapy for TB in HIV-infected persons:international recommendations, research, and practice[J]. The Lancet,1995,345:833-836.
[7] Ferebee SH. Controlled chemoprophylaxis trials in TB:A general review[J]. Adv Tuberc Res,1970,17:28-106.
[8] Pamra SP, Mathur GP. Effects of chemoprophyiaxis on minimal pulmonary TB lesions of doubtful activity [J]. Bull World Health Organ,1971,45:593-602.
[9] Graybowski S, Ashely MJ, Pincus G. Chemoprophylaxis in inactive TB:long-term evaluation of a Canadian trial[J]. Can Med Assoc J,1976,114:607-611.
[10] Wadhawan D, Hira SK, Mwansa N, et al. Preventive tuberculosis chemotherapy with isoniazid among persons infectedly HIV[S]. VII international conference on AIDS, Florence, Italy, 16-20 June 1991. Abstract WB 2261:247.
[11] Pape JW, Jean SS, Ho JL, et al. Effect of isoniazid prophylaxis on incidence of active TB and progression of HIV infection [J]. Lancet,1993,342:268-272.
[12] Wilkinson D, Squire SB, Garner P. Effect of preventive treatment for TB in adults infected with HIV:systematic review of randomised placebo controlled trials[J]. BMJ, 1998,317(7159):625-629.
[13] Lecoeur HF, tniffot-Pemot C, Grosset JH. Experimental short-course preventive therapy of TB with RFP and PZA[J]. Am Rev Re-spir Dis,1989,140:1189-1193.
[14] Chermont H, Johnson M, Coberiy J, et al. Tolerance of short-cource TO chemoprophylaxis in HIV infected individuals[S]. VH intematicxial ccrference on AIDS, Florence, Italy, 16-20 June 1991. Abstract WB2363:273.
[15] Lucas B, Hounnon A, Peacock C,et al. The mortality and pathology of HIV infection in a West African city[J]. AIDS, 1993,7:1569-1579.
[16] Bell JC, Rose DN,Sacks HS. TB preventive therapy for HIV infected people[J]. AIDS, 1999,13(12):1549-1556.
[17] Mwinga A. Twice weekly TB preventive therapy in HTV-infected in Zambia[J]. AIDS, 1998,12(18)2447-2457.
[18] Guelar A, Getell JM, Podzamczer D, et al. A prospective study of the risk of TB among HIV-infected patients[J]. AIDS, 1993,7:1345-1349.
[19] Halsey NA, Coberiy JS, Desormeanx J, et al. Randomised trial of INH versus RFP and PZA for preventive of TB in HIV Iinfection[J]. Lancent,1998,351(9105):786-792.
[20] Prignot J, Perriens JH, St Louis ME, et al. Should the 2H2R2Z2E2-4H2R2 regimen be extended for smear positive pulmonary TB in HIV1 infected patients? [S]. 28th Worid Congress of IUATLD/ UICTCMR, Mainz, June 14-17,1994:abstr 3.
[21] CDC. PPD-tuberculin and HTV infection: guidelines for anergy testing and management of anergic persons at risk of TB infection recommendations[R]. MMWR, 1991,40[No.RR-5] :27-33.
[22] CDC. Anergy skin testing and TB preventive therapy for HIV-infected persons:revised recommendations[R]. MMWR, 1997,46(RR-15):1-10.
[23] WHO, IUATLD. TB preventive therapy in HIV-infected individuals. A joint statement of the IUATLD and the Global Program on AIDS and the TB Program of WHO[J]. Weekly Epigemiological Record, 1993,68:361-368.
[24] WHO. Preventive TB chemotherapy among persons infected with HTV [R]. Report of an informal consultation, 6-8 February 1990. Document WHO/TUB/AIDS/90.1
[25] CDC, Screening for TB and tuberculous infection in high risk populaticxis and the use of preventive therapy for TB infection in the United Stales[R]. MMWR,1990,39(RR-8):1-12.
[26] Hflwken MP, Muhindi DW. TB preventive therapy in HIV infected persons:feasibility issues in developing countries[J].Int J Tuberc Lung Dis,1999,3(8):646-650.
[27] Aisu T.Raviglione MC, Van Prang E, et al. Preventive chemotherapy for HIV-associated TB in Uganda: an operational assessment at a voluntary counseling and testing center [J]. AIDS,1995,9(3):267-273.
|